Encompass Health (EHC) Receivables (2009 - 2026)

Encompass Health has reported Receivables for 18 years, with the latest figure at $676.0 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables rose 8.44% year-over-year to $676.0 million; the trailing twelve-month figure through Mar 2026 stood at $676.0 million (up 8.44% YoY), and the FY2025 full-year result was $619.2 million, up 3.41% from the prior year.
• Receivables for Q1 2026 stood at $676.0 million, up from $619.2 million in the prior quarter.
• The five-year high for Receivables was $683.5 million in Q1 2022, with the low at $500.1 million in Q3 2022.
• Historically, Receivables has averaged $594.1 million across 5 years, with a median of $610.8 million in 2025.
• Annual changes were most pronounced in 2023 — Receivables slipped 24.73% — and 2024, when it increased 20.37%.
• Encompass Health's Receivables stood at $536.8 million in 2022, then increased by 13.93% to $611.6 million in 2023, then retreated by 2.09% to $598.8 million in 2024, then climbed by 3.41% to $619.2 million in 2025, then climbed by 9.17% to $676.0 million in 2026.
• The last three Receivables figures came in at $676.0 million (Q1 2026), $619.2 million (Q4 2025), and $610.8 million (Q3 2025), per Business Quant data.